Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation

Antonio Lopez-Beltran1, Liang Cheng2, Lennart Andersson3, Maurizio Brausi4, Anna de Matteis5, Rodolfo Montironi6, Isabell Sesterhenn7, Theodorus van der Kwast8, Catherine Mazerolles9
1Department of Pathology, Cordoba University Medical School, Facultad de Medicina, Avda. Menendez Pidal s/n, 14004 Cordoba, Spain
2Division of Surgical Pathology, Indiana University Medical Center, Indianapolis, USA
3WHO Center for Urologic Tumors, Karolinska Hospital, Stockholm, Sweden
4Urology Service, Estense-Sant'Agostino Hospital, Modena, Italy
5Department of Experimental Medicine and Pathology, Policlinico Umberto 1, Roma, Italy
6Institute of Pathological Anatomy and Histopathology, University of Ancona School of Medicine, Torrette di Ancona, Italy
7Division of Genitourinary Pathology, AFIP, Washington, DC, USA
8Department of Pathology, Erasmus University, Rotterdam, The Netherlands
9Laboratoire d'Anatomie Pathologique, Hôpital Purpan, Toulouse, France

Tóm tắt

Background and aims: This paper summarizes the work done by the members of the Committee no. 2 at the International Consultation on the Diagnosis of Non-Invasive Urothelial Neoplasms held in Ancona, Italy (11–12 May 2001). The committee members discussed and reached consensus regarding the optimal contemporary diagnosis and classification of the preneoplastic non-papillary lesions of the urothelium. An important objective was to promote a precise terminology and to use it consistently in daily practice in pathology and urology. Results and conclusions: The result of the meeting is represented by a refined classification of the non-papillary intraepithelial lesions and conditions of the urothelium. This classification includes epithelial abnormalities (reactive urothelial atypia and flat urothelial hyperplasia), presumed preneoplastic lesions and conditions (keratinizing squamous and glandular metaplasia, and malignancy-associated cellular changes), as well as preneoplastic (dysplasia) and neoplastic non-invasive (carcinoma in situ) lesions. Each of these lesions is defined with strict morphological criteria in order to provide more accurate information to urologists in managing patients.